High Evidence (L1-L2)
Candidates that may be prioritised for clinical evaluation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L1 | Multiple Phase 3 RCTs / systematic reviews | Strong support; clinical use may be considered |
| L2 | Single RCT or multiple Phase 2 trials | Moderate support; validation trials can be designed |
L1 (53 drugs)
| Drug | Indications | Link |
|---|---|---|
| Agomelatine | 10 | View report |
| Ambrisentan | 10 | View report |
| Anastrozole | 10 | View report |
| Aripiprazole | 10 | View report |
| Asenapine | 10 | View report |
| Atazanavir | 6 | View report |
| Atomoxetine | 10 | View report |
| Atorvastatin | 6 | View report |
| Azathioprine | 10 | View report |
| Bilastine | 10 | View report |
| Bromfenac | 10 | View report |
| Bupropion | 10 | View report |
| Busulfan | 10 | View report |
| Calcitriol | 7 | View report |
| Cefixime | 10 | View report |
| Celecoxib | 10 | View report |
| Cetirizine | 6 | View report |
| Clomipramine | 10 | View report |
| Clopidogrel | 10 | View report |
| Dapsone | 1 | View report |
| Desloratadine | 6 | View report |
| Dexketoprofen | 10 | View report |
| Diazepam | 10 | View report |
| Dronedarone | 10 | View report |
| Ethanolamine Oleate | 10 | View report |
| Ezetimibe | 4 | View report |
| Fenbufen | 10 | View report |
| Flunarizine | 10 | View report |
| Flurbiprofen | 10 | View report |
| Haloperidol | 10 | View report |
| Hydroxyurea | 10 | View report |
| Imiquimod | 10 | View report |
| Lormetazepam | 10 | View report |
| Memantine | 4 | View report |
| Mercaptopurine | 10 | View report |
| Midodrine | 10 | View report |
| Nizatidine | 7 | View report |
| Pantoprazole | 6 | View report |
| Reboxetine | 10 | View report |
| Rifabutin | 10 | View report |
| Risperidone | 6 | View report |
| Salmeterol | 7 | View report |
| Sertraline | 8 | View report |
| Simvastatin | 8 | View report |
| Tacrolimus | 3 | View report |
| Temozolomide | 2 | View report |
| Tioconazole | 10 | View report |
| Tiotropium | 10 | View report |
| Tolfenamic Acid | 10 | View report |
| Tolvaptan | 10 | View report |
| Trastuzumab | 10 | View report |
| Zidovudine | 6 | View report |
| Zolmitriptan | 3 | View report |
L2 (58 drugs)
| Drug | Indications | Link |
|---|---|---|
| Acetazolamide | 10 | View report |
| Acrivastine | 6 | View report |
| Albendazole | 10 | View report |
| Aztreonam | 10 | View report |
| Bimatoprost | 10 | View report |
| Capecitabine | 10 | View report |
| Ciprofibrate | 10 | View report |
| Citalopram | 5 | View report |
| Clonidine | 10 | View report |
| Clozapine | 10 | View report |
| Dasatinib | 10 | View report |
| Dexibuprofen | 10 | View report |
| Diflunisal | 10 | View report |
| Emedastine | 2 | View report |
| Epinastine | 10 | View report |
| Etanercept | 6 | View report |
| Etodolac | 10 | View report |
| Everolimus | 10 | View report |
| Fenoprofen | 10 | View report |
| Guaifenesin | 10 | View report |
| Lamotrigine | 9 | View report |
| Latanoprost | 10 | View report |
| Lenalidomide | 6 | View report |
| Levamisole | 10 | View report |
| Mefenamic Acid | 8 | View report |
| Methylphenidate | 4 | View report |
| Midazolam | 1 | View report |
| Moclobemide | 2 | View report |
| Montelukast | 5 | View report |
| Mycophenolate Mofetil | 10 | View report |
| Nefopam | 10 | View report |
| Olmesartan | 10 | View report |
| Omalizumab | 10 | View report |
| Paliperidone | 10 | View report |
| Pazopanib | 10 | View report |
| Phenylbutazone | 10 | View report |
| Pimecrolimus | 4 | View report |
| Pirenzepine | 2 | View report |
| Piroxicam | 10 | View report |
| Pivmecillinam | 10 | View report |
| Prednisolone | 10 | View report |
| Propranolol | 6 | View report |
| Ranitidine | 10 | View report |
| Rizatriptan | 2 | View report |
| Ropivacaine | 10 | View report |
| Selegiline | 4 | View report |
| Sirolimus | 10 | View report |
| Sorafenib | 10 | View report |
| Sunitinib | 10 | View report |
| Temazepam | 1 | View report |
| Tenoxicam | 10 | View report |
| Tetracycline | 4 | View report |
| Ticagrelor | 10 | View report |
| Tizanidine | 10 | View report |
| Topotecan | 10 | View report |
| Trazodone | 10 | View report |
| Valproic Acid | 10 | View report |
| Ziprasidone | 10 | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)